T1	Chemical	49 61	capecitabine
T2	Disease	73 99	pancreatic cancer patients
T3	Limited_variation	114 154	TYMS * 2 / * 2 variant may be associated
T4	Pharmacodynamic_phenotype	170 196	non-hematologic toxicity .
R1	treats	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	increases	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T2	Arg2:T1
R5	isAssociatedWith	Arg1:T2	Arg2:T3
R6	increases	Arg1:T2	Arg2:T4
R7	influences	Arg1:T3	Arg2:T1
R8	isAssociatedWith	Arg1:T3	Arg2:T2
R9	increases	Arg1:T3	Arg2:T4
R10	isAssociatedWith	Arg1:T4	Arg2:T1
R11	isAssociatedWith	Arg1:T4	Arg2:T2
R12	isAssociatedWith	Arg1:T4	Arg2:T3
